Stock listing

Vericel Corporation

Selected listing: ATQP · MUN · EUR · DE

Vericel Corporation (Munich:ATQP), Health Technology. Latest release Sep 8, 2026: Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare…

ATQP:MUNEURDEUpdated October 2, 2026

Ticker: Munich:ATQP
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

About Vericel Corporation

The company focuses on developing and commercializing advanced cell therapies for patients with unmet medical needs. Vericel is dedicated to improving patient outcomes through innovative treatments.

Latest news from Vericel Corporation

Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026

September 8, 2026

Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

July 30, 2026

Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026

July 16, 2026

Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026

June 8, 2026

Carticel Sm Service (Vericel) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

May 7, 2026

All Vericel Corporation news →

Events

Replays

Vericel Corporation (VCEL) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 08:30 AM ET
Watch
Vericel Corporation (VCEL) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:30 AM ET
Watch
Vericel Corporation (VCEL) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:30 AM ET
Watch

Research Vericel Corporation

Vericel Corporation company profile

View the public company page for Vericel Corporation on 6ix.

Vericel Corporation news

Read company news and market updates connected to Vericel Corporation.

Vericel Corporation investor events

Find investor webinars, events, and replay context for Vericel Corporation.